Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Levulan photodynamic therapy
Seven reasons to buy DUSA Pharmaceuticals
Seven reasons to buy DUSA Pharmaceuticals
Seeking Alpha
dermatology
DUSA pharmaceuticals
Levulan photodynamic therapy
DUSA Pharmaceuticals Is A Small Gem
DUSA Pharmaceuticals Is A Small Gem
Seeking Alpha
DUSA pharmaceuticals
Levulan photodynamic therapy
Dusa Pharma says skin treatment sales continued to rise in 1st quarter; stock jumps
Dusa Pharma says skin treatment sales continued to rise in 1st quarter; stock jumps
Yahoo/AP
DUSA pharmaceuticals
earnings
Levulan photodynamic therapy
DUSA: A Pharmaceutical With Profits Now and Strong Growth Ahead
DUSA: A Pharmaceutical With Profits Now and Strong Growth Ahead
Seeking Alpha
DUSA pharmaceuticals
Levulan photodynamic therapy
News
DUSA Pharmaceuticals: Small-Cap Biotech With a Healthy Cash Flow
Seeking Alpha
dermatology
DUSA pharmaceuticals
Levulan photodynamic therapy
PDT
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT